Swadesh K. Das

Eastern Regional Station
Kalyani, WB 741235, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 300 publications

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: July 06, 2026

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: July 06, 2026

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Cancer terminator viruses: Unique conditionally replication competent oncolytic viruses producing therapeutic anti-cancer immunomodulating agents.

Journal: Advances in cancer research

Published: June 05, 2026

IVMT-Rx-3 Microemulsion as Low-Dose Metronomic Chemotherapy for Melanoma Metastasis.

IVMT-Rx-3 Microemulsion as Low-Dose Metronomic Chemotherapy for Melanoma Metastasis.

Journal: Cells

Published: December 29, 2025

MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis.

MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasis.

Journal: Pharmacological research

Published: December 16, 2025

Targeting MDA-9/Syntenin-1 (SDCBP) as a Strategy to Eliminate Head and Neck Squamous Cell Carcinoma Stem Cells.

Targeting MDA-9/Syntenin-1 (SDCBP) as a Strategy to Eliminate Head and Neck Squamous Cell Carcinoma Stem Cells.

Journal: Cancer letters

Published: December 04, 2025

Substituted 1-(benzo[d]thiazol-2-yl)-3-phenylurea derivatives as anti-invasion agents.

Substituted 1-(benzo[d]thiazol-2-yl)-3-phenylurea derivatives as anti-invasion agents.

Journal: Bioorganic & medicinal chemistry letters

Published: November 27, 2025

Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications.

Epigenetic mechanisms and therapeutic advances in breast cancer: From molecular insights to clinical applications.

Journal: Advances in cancer research

Published: November 16, 2025

PROTACS- targeted protein degradation as a path to precision cancer therapeutics.

PROTACS- targeted protein degradation as a path to precision cancer therapeutics.

Journal: Advances in cancer research

Published: November 16, 2025

NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistance.

NR2F1 and mTORC1 provide the bridge between melanoma dormancy and therapeutic resistance.

Journal: The Journal of clinical investigation

Published: September 16, 2025

Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resource.

Making deep immunophenotyping accessible: the successful application of a guided 23-parameter mouse immunophenotyping panel package provided through a shared resource.

Journal: Frontiers in immunology

Published: July 17, 2025

Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer.

Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer.

Journal: Journal for immunotherapy of cancer

Published: April 08, 2025

Showing 1-12 of 300

Last Updated: 09/26/2026